Effects of Modified FOLFOX-6 Chemotherapy on Cellular Immune Function in Patients With Gastric Cancer

Oncology Letters - Greece
doi 10.3892/ol.2018.8361
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Oxaliplatin, 5-Fluorouracil and Leucovorin (Modified FOLFOX-6) as First-Line Chemotherapy for Advanced Gastric Cancer Patients With Poor Performance Status

Oncology Letters
Cancer ResearchOncology
2011English

A Phase II Study of Modified FOLFOX as First-Line Chemotherapy for Metastatic Gastric Cancer in Elderly Patients With Associated Diseases

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2012English

A Comparative Study of Treatment Toxicities Between FOLFOX 4 and Modified FOLFOX 6 in Iranian Colorectal Cancer Patients

Iranian Journal of Cancer Prevention
2017English

Effects of Nutritional Factors on Cellular Immune Function.

Nippon Eiyo Shokuryo Gakkaishi
1991English

Comparative Analysis of the Efficacy and Safety of Modified FOLFOX-6 and DCF Regimens as First-Line Treatment in Advanced Gastric Cancer

Molecular and Clinical Oncology
Cancer ResearchOncology
2015English

Systemic Chemotherapy With FOLFOX in Metastatic Grade 1/2 Neuroendocrine Cancer

Molecular and Clinical Oncology
Cancer ResearchOncology
2016English

The Effects of Chemotherapy on the Contrast Sensitivity Function of Breast Cancer Patients

International Journal of Psychological Studies
2011English

FOLFOX as Second-Line Chemotherapy in Patients With Pretreated Metastatic Pancreatic Cancer From the FIRGEM Study

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

Compliance of Patients With Locally Advanced Colorectal Cancer to Chemotherapy Using FOLFOX Compared to XELOX Regimen

The New Ropanasuri Journal of Surgery
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy